Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

154.18
Delayed Data
As of May 04
 -2.17 / -1.39%
Today’s Change
130.09
Today|||52-Week Range
181.81
-5.02%
Year-to-Date

Today’s Trading

Previous close156.35
Today’s open155.28
Day’s range153.53 - 155.86
Volume3,048,430
Average volume (3 months)3,655,978
Market cap$119.2B
Dividend yield2.59%
Data as of 05/04/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+6.76%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.49%
P/E ratio17.0
Price/Sales5.83
Price/Book4.27

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-1.57-1.80%
BIIBBiogen-10.59-3.87%
BXLTBaxalta Inc-0.91-2.15%
BAXBaxter International...+0.73+1.64%
Data as of 05/04/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$2.74
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhavan Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers

Search for Jobs